Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%
| Status: | Archived |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2010 |
The purpose of this study is to evaluate the safety and efficacy of FID 112903 given as an
immediate treatment replacement in dry eye subjects that discontinue at least 6 months use
of RESTASIS.
We found this trial at
1
site
Alcon Call Center Alcon is helping people see the world better through advanced surgical, pharmaceutical...
Click here to add this to my saved trials
